Bio Protocol vs RSS3 — how do they compare? Bio Protocol trades at Rp442.62 (market cap Rp1T, Rp177,9M 24h volume), while RSS3 trades at Rp101.77 (market cap Rp82,23M, Rp28,18M 24h volume). The key difference: Bio Protocol is far larger — about 12161× RSS3's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 906,2M / 1B RSS3 (91%) for RSS3. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and RSS3 for 20 Days on average.
| BIO | RSS3 | |
|---|---|---|
Market Cap | Rp1T | Rp82,23M |
Volume (24h) | Rp177,9M | Rp28,18M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 906,2M / 1B RSS3 (91%) |
Typical Hold Time | 17 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
RSS3 shows limited market activity with a modest market cap of Rp82.23M and 91% circulating supply. The token trades with a 20-day average hold time, indicating relatively stable short-term holding patterns. Current technical positioning suggests consolidation with low volatility, though specific price action data is unavailable. No major protocol updates or ecosystem developments have been reported recently, leaving the project in a quiet phase.
Overall outlook remains cautious due to low liquidity and limited market presence. Key opportunities include potential ecosystem growth if development resumes, while major risks involve low trading volume vulnerability and regulatory uncertainty common to smaller crypto assets. Investors should monitor for renewed developer activity and exchange listings.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →RSS3 is the Open Information Layer, structuring open information for the next Twitter, Google, and OpenAI. The RSS3 Network is formed by decentralized nodes that consistently index and structure information from the Open Web, ensuring its availability and accessibility for all.
Read more on RSS3 →